Attached files
file | filename |
---|---|
EX-21 - LIST OF SUBSIDIARIES - Accelerate Diagnostics, Inc | accelerate12312014exh21.htm |
EX-32 - CERTIFICATION - Accelerate Diagnostics, Inc | accelerate12312014exh32.htm |
EX-31.1 - CERTIFICATION - Accelerate Diagnostics, Inc | accelerate12312014exh311.htm |
EX-31.2 - CERTIFICATION - Accelerate Diagnostics, Inc | accelerate12312014exh312.htm |
EX-23.2 - CONSENT - Accelerate Diagnostics, Inc | accelerate12312014exh232.htm |
EXCEL - IDEA: XBRL DOCUMENT - Accelerate Diagnostics, Inc | Financial_Report.xls |
10-K - FORM 10-K - Accelerate Diagnostics, Inc | accelerateddia12312014.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-187439) pertaining to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan, | |
(2) | Registration Statement (Form S-3 No. 333-192321) of Accelerate Diagnostics, Inc., | |
(3) | Registration Statement (Form S-3 No. 333-194474) of Accelerate Diagnostics, Inc., and | |
(4) | Registration Statement (Form S-8 No. 333-199992) pertaining to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan; |
of our reports dated February 26, 2015, with respect to the financial statements of Accelerate Diagnostics, Inc. and the effectiveness of internal control over financial reporting of Accelerate Diagnostics, Inc., included in this Annual Report (Form 10-K) of Accelerate Diagnostics, Inc. for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Phoenix, Arizona
February 26, 2015